-->

Biotech wants emergency FDA approval for coronavirus test

Organisation: Position: Deadline Date: Location:

Biotechnology company Novacyt has applied for emergency approval from the US Food and Drug Administration (FDA) as it races to roll out a product that tests for the coronavirus, reports Reuters Health. Novacyt, which is listed in Paris and London, also said it was in talks with public sector hospitals in Britain.

“As one of the first companies to develop and launch a test to detect the 2019 strain of nCoV (coronavirus), we have received unprecedented interest,” Novacyt CEO Graham Mullis said.

“We continue to support our new and existing customers and are working with the various regulatory authorities to try to make our nCoV test available to as many countries and laboratories as possible,” he added.

Full Reuters Health

Receive Medical Brief's free weekly e-newsletter



Related Posts

Thank you for subscribing to MedicalBrief


MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.


Thank you for taking the time to complete the form.